Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes From a Randomized Clinical Trial
- PMID: 28302269
- DOI: 10.1016/j.ajo.2017.01.035
Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes From a Randomized Clinical Trial
Comment in
-
Reply.Am J Ophthalmol. 2017 May;177:233. doi: 10.1016/j.ajo.2017.02.010. Epub 2017 Mar 11. Am J Ophthalmol. 2017. PMID: 28292461 No abstract available.
Comment on
-
Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes From a Randomized Clinical Trial.Am J Ophthalmol. 2016 Oct;170:206-213. doi: 10.1016/j.ajo.2016.08.008. Epub 2016 Aug 12. Am J Ophthalmol. 2016. PMID: 27523491 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical